X0206 3 2025-03-06 0 0001754195 Trulieve Cannabis Corp. TRUL 0001983133 Blust Ryan 6749 BEN BOSTIC ROAD QUINCY FL 32351 0 1 0 0 Interim CFO Subordinate Voting Shares 54298 D Stock Option (Right to Buy) 33.42 2026-01-04 Subordinate Voting Shares 7497 D Stock Option (Right to Buy) 26.88 2028-09-29 Subordinate Voting Shares 19458 D Stock Option (Right to Buy) 21.48 2029-02-24 Subordinate Voting Shares 24860 D Stock Option (Right to Buy) 3.99 2030-07-24 Subordinate Voting Shares 56442 D Stock Option (Right to Buy) 10 2031-03-08 Subordinate Voting Shares 33114 D The amount of securities beneficially owned in column 2 includes two grants of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. The reporting person was granted: (i) 25,364 RSUs on July 25, 2023, subject to 2-year vesting; the RSUs vested 50% on December 1, 2024 and will vest 50% on December 1, 2025; and (ii) 18,288 RSUs on March 8, 2024, subject to 2-year vesting; the RSUs will vest 50% on December 1, 2025 and 50% on December 1, 2026. The options were granted on January 4, 2021. As of December 31, 2023, all of the options were fully vested and exercisable. The options were granted on September 29, 2021. As of December 1, 2023, all of the options were fully vested and exercisable. The options were granted on February 24, 2022. As of December 1, 2024, all of the options were fully vested and exercisable. The options were granted on July 25, 2023, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on December 1, 2023; one third of the options vested and became exercisable on December 1, 2024; and one third of the options will vest and become exercisable on December 1, 2025. The options were granted on March 8, 2024, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on December 1, 2024; one third of the options will vest and become exercisable on December 1, 2025; and one third of the options will vest and become exercisable on December 1, 2026. /s/ Ryan Blust 2025-03-11